Article
Evidence for oxazepam as an<i>in vivo</i>probe of UGT2B15: oxazepam clearance is reduced by<i>UGT2B15</i>D85Y polymorphism but unaffected by<i>UGT2B17</i>deletion
7 Aug 2009
Abstract excerpt
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • UDP‐glucuronosyltransferase (UGT) 2B15 is a major drug glucuronidation enzyme expressed in human liver. • Oxazepam is an isoform‐selective probe drug that is being used for in vitro studies of UGT2B15. • The most common UGT2B15 missense polymorphisms (D85Y and K523T) are correlated with variable oxazepam glucuronidation in human liver bank samples. • UGT2B17 is also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
